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Introduction
[5.1] It seems natural to think that shareholders are principals and that directors
act as their agents. The relationships among shareholders and directors result
from consensual association, as do relationships that fall within the common-law
definition of agency. Shareholders choose a corporation’s directors by electing
them to office. Once installed in office, directors hold discretionary management
power over the corporation and thus make decisions that affect the economic
well-being of shareholders. In exercising their managerial power, directors are
subject to fiduciary duties, as are agents when acting within the scope of the
agency relationship. The object of fiduciary duties is assuring loyal service to
the interests of the corporation, conventionally defined by the interests of its
shareholders, or by the interests of an agent’s principal. That fiduciary duties
are not self-enforcing creates a risk of divergence between the use that directors
or agents may make of their powers and the use that would best serve the interests of shareholders or principals. These similarities underlie conventional aca∗ David F Cavers Professor of Law, Duke University School of Law. I am grateful to
Professor Paul Davies for his comments on an earlier draft.
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demic terminology. In analyzing the structure of relationships among directors
and shareholders, economists and many academic lawyers use as commonplace
terminology terms like “agency problem,” “agency cost,” and “agent-principal
relationship.”1

Despite these similarities, the relationship between shareholders and directors is not one of common-law agency. Reasoning by analogy on the basis of
observed similarities is, of course, a conventional source of insight. Passing too
quickly over dissimilarities leads to confusion, not insight. Contemporary corporate law does not treat directors as shareholders’ agents other than in a loose
or metaphorical sense. If fully applicable to directors’ relationships to shareholders, the common law of agency would destabilize the legal consequences
that contemporary corporate law facilitates. Although this point is basic, it is
also a potentially rich source of insight into differences between corporate law
1 See, eg, Michael C Jensen & William H Meckling, ‘Theory of the Firm: Managerial
Behavior, Agency Costs and Ownership Structure’, J Fin Econ, Vol 3, 1976, p 308; Frank H
Easterbrook & Daniel R Fischel, The Economic Structure of Corporate Law (1991). Some
of this work defines as relationships of agency ones that would fall outside the definition of
common-law agency. See, eg, Jensen & Meckling at 308 (defining an “agency relationship”
as a “contract under which one or more persons (the principal(s)) engage another person
(the agent) to perform some service on their behalf which involves delegating some decision
making authority to the agent.”). Judicial opinions occasionally use agency terminology in this
generalised sense as well. See, eg, Blasius Indus, Inc v Atlas Corp (Del Ch 1988) 564 A2d 651
at 660 (“a decision by the board to act for the primary purpose of preventing the effectiveness
of a shareholder vote inevitably involves the question who, as between the principal and
the agent, has authority with respect to a matter of internal corporate governance....Action
designed principally to interfere with the effectiveness of a vote inevitably involves a conflict
between the board and a shareholder majority. Judicial review of such action involves a
determination of the legal and equitable obligations of an agent toward his principal. This is
not, in my opinion, a question that a court may leave to the agent finally to decide so long
as he does so honestly and competently; that is, it may not be left to the agent’s business
judgment.”). For a thoughtful discussion of the role the law of agency plays in defining
relationships within firms, see Eric W Orts, ‘Shirking and Sharking: A Legal Theory of the
Firm’, Yale L & Pol’y Rev, Vol 16, 1998, p 265.
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in the United States and the Anglo-Commonwealth jurisdictions and into relationships between corporation-law statutes and common-law doctrines. It also
affords a useful starting point for analyzing a current and controversial issue in
the United States, which is whether shareholders have or should have power to
give binding instructions to directors to redeem a poison pill or condition the
circumstances under which directors may adopt or renew a poison pill. Finally,
the basic point also provides a start for understanding limits on the efficacy of
shareholder voting as a device to exonerate directors against claims for breach
of fiduciary duty. In the United States, the relationship between shareholders
and directors comes closest to one of common-law agency when the directors’
action could not rationally serve any corporate purpose.
[5.2] This paper begins by with a brief explication of the consequences of characterising a relationship as one of common-law agency. It then sketches the complex relationships between corporation-law statutes and extra-statutory doctrines drawn from the common law and equity. Against this background the
paper next analyzes implications to be drawn from the structure of contemporary corporation statutes for the allocation of power as between shareholders
and directors. The paper then develops the import of this analysis when shareholders seek to compel the redemption of a poison pill by directors, contrasting
developments in the United States with the United Kingdom and Australia. The
basic point is that the metaphorical association with common-law agency is generally not helpful, given the structure of contemporary corporation statutes, and
may be affirmatively misleading.
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The common-law definition and its consequences

[5.3] It is helpful to begin with a brief sketch of consequences that would
follow were the relationship between a corporation’s shareholders and its directors treated as an instance of common-law agency, for ousting many of those
consequences is a major accomplishment of contemporary corporate law. As
defined by the Restatement of Agency, “[a]gency is the fiduciary relationship
that arises when one person (a “principal”) manifests assent to another person
(an “agent”) that the agent shall act on the principal’s behalf and subject to
the principal’s control, and the agent manifests assent or otherwise consents so
to act.”2 The definition requires that the agent act subject to the principal’s
control. Within the common law of agency, control is a loosely-structured concept for which specific meanings vary with context.3 Conventionally, though,
control encompasses a principal’s power to give interim instructions to an agent,
even when the principal has previously agreed not to do so.4
[5.4] Three other consequences of immediate note follow once a relationship falls
within the common-law definition. First, the principal, whether or not disclosed,
becomes a party to transactions and subject to other obligations entered into by
the agent within the scope of the agent’s actual or apparent authority. Second,
2 See

Restatement Third, Agency §1.01 (Tentative Draft No 2, 2001).
id § 1.01, Comment f.
4 See id. The power to dominate or influence is not identical to the concept of control for
purposes of determining whether a relationship is one of common-law agency. See id. Nor
do declarations by parties determine how a court should characterise a relationship. See id §
1.02; accord, South Sydney District Rugby League Football Club Ltd v News Ltd [2000] FCA
1541 at ¶¶ 131-67.
3 See
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assets managed by the agent on behalf of the principal become vulnerable to
claims asserted by the principal’s creditors, whether or not the claims are related
to the assets or to the agent’s activity.5 Third, the principal may revoke the
agent’s actual authority at any time by making a manifestation to that effect
to the agent, even though the revocation contravenes the terms of a contract
between principal and agent.6

[5.5] The first two of these consequences of common-law agency are neatly
side-stepped by the basic consequence of forming a corporation. Once formed,
a corporation is itself a juridical person that holds rights and becomes subject
to obligations, thereby insulating its shareholders from individual liability as
well as insulating its assets from claims asserted by shareholders’ individual
creditors. It may be less immediately evident why the third consequence is so
important. A principal’s power to revoke an agent’s authority is a fundamental
means by which the principal exercises control and self-protects against the risks
present in a relationship in which another person’s actions directly affect the
principal’s legal relations with third parties.7
Suppose each shareholder had an individual relationship of common-law agency
5 For an extended discussion of the relative significance of these two points, see Henry
Hansmann and Reinier Kraakman, ‘The Essential Role of Organizational Law’, Yale LJ, Vol
110, 2000, p 387.
6 See Restatement Third, Agency § 3.10 (1). Likewise, an agent has power to renounce
actual authority although the renunciation contravenes an agreement with the principal. See
id. English law is to the same effect. See Francis Reynolds, ‘When is an Agent’s Authority Irrevocable?’, in Making Commercial Law: Essays in Honour of Roy Goode 259 (Ross
Cranston ed 1997).
7 See Restatement Third, Agency § 3.10, Comment b.
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with each of the corporation’s directors. Each shareholder would then be situated as a co-principal in an agency relationship with multiple co-agents and
would hold power to revoke each director’s authority, regardless of any agreement to the contrary.8 Moreover, a shareholder’s death or loss of capacity would
terminate the directors’ authority. Directors would as a consequence lack the
ability to deal on a reliable footing with third parties, who could not prudently
commit to be bound by a transaction without direct confirmation from each of
the shareholders. Indeed, even the otherwise-robust doctrine of apparent authority might not assist third parties seeking to enforce a liability incurred by
a director on behalf of the shareholder-principals if reasonable people would be
aware of the fragility of directors’ authority. This is because the doctrine of
apparent authority does not protect a third party who acts on the basis of an
unreasonable belief that an agent has authority. Thus, treating a corporation as
itself the principal that is bound by actions taken by its directors, officers, employees, and other agents overcomes what would otherwise be serious practical
problems that would, at a minimum, delay the formation of mutually binding
contracts.
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Nor are these problems successfully overcome by treating a majority of share8 See

id §§ 3.07(2) and 3.08(1). This feature of agency law differentiates it from contract
law. For an examination of the stability that mutually enforceable contracts may create, see
E Allan Farnsworth, Changing Your Mind: The Law of Regretted Decisions (1998).
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holders as a single “principal,” as opposed to positing that an individual relationship of agency exists between each shareholder and each director. Shareholders
take action collectively on the basis of voting through which the outcome is
determined by some variant of majority rule, which could encompass a plurality
of votes cast, a majority of a specified proportion of votes cast, or a majority of
shares outstanding. A third party seeking to confirm a director’s authority to
take action could do so only by inquiry to shareholders, an aggregate body of
potentially fluid membership, a majority of whose members at any time would
constitute the “principal.” Moreover, if the director acted with authority in
entering into a transaction, who would become a party to the transaction as a
consequence? All of the shareholders? Or only a specifically assenting majority? Thus, deeming a majority of a corporation’s shareholders to constitute the
“principal” would not result in a stable or predictable outcomes.
The evolution of shareholders’ powers
[5.6] In an earlier era, corporate law treated shareholders as principals in a more
than metaphorical sense by empowering shareholders to exercise control over directors by giving binding instructions. Directors were “subject to the superior
control of the proprietors assembled in general meetings,”9 expressed in resolutions that shareholders adopted by majority vote at the meeting. Over time,
commercial opinion rejected this structure, legislatures responded, and courts
“elevated the board from being merely agents to being a primary organ,”10
9 Foss v Harbottle [1843] 67 ER 189, 2 Hare 461. See also Jennifer Hill, Visions and
Revisions of the Shareholder, 48 Am J Comp L 39, 42-44 (2000).
10 H A J Ford, R P Austin, and I M Ramsay, Ford’s Principles of Corporations Law 217
(10th ed 2001).
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an instrumentality of governance holding management power that is distinct
from shareholders. In the United States, this transformation was accomplished
through

corporation statutes that articulate specific powers held by shareholders and
otherwise allocate managerial power to directors, thereby eliminating the power
previously held by a majority of shareholders to give binding instructions to
directors through the mechanism of adopting a resolution.11 For example, section 141(a) of Delaware’s corporation statute provides that “[t]he business and
affairs of every corporation organized under this [statute] shall be managed by
or under the direction of a board of directors, except as may be otherwise provided in this [statute] or in its certification of incorporation.” Contemporary
corporation statutes in the United States also specify instances in which a shareholder vote is necessary; these include electing directors at an annual meeting,
as well as amending the corporation’s certificate of incorporation and approving
fundamental transactions, each initiated by a resolution adopted by directors.
[5.7] As stated recently by the Delaware Supreme Court in Quickturn Design
Systems v Mentor Graphics Corp, “[o]ne of the most basic tenets of Delaware
corporate law is that the board of directors has the ultimate responsibility for
managing the business and affairs of a corporation.”12 Delaware’s corporate
law is of particular significance because it has long been the dominant state
11 See Auer v Dressel (NY 1954) 118 NE2d 590 (shareholders lack power to compel directors to re-hire corporation’s former President; shareholders may properly adopt precatory
resolution urging board to rehire former President).
12 Quickturn Design Sys, Inc v Mentor Graphics Corp (Del 1998) 721 A2d 1281 at 1291.
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for incorporations of public corporations; the Delaware Supreme Court, in the
words of a prominent federal judge, is the “Mother Court” of corporate law.13
But the Delaware structure, predominant throughout the United States, is not
followed uniformly elsewhere. As discussed in [5.12], in the United Kingdom and
Australia, directors do not hold managerial authority as the result of a direct
statutory grant but instead as the result of provision made in a corporation’s
articles or constitution. Moreover, while shareholders in the United Kingdom
and Australia have unilateral power to amend this document, shareholders in a
Delaware corporation lack unilateral authority to amend its certificate of incorporation. See [5.10].
Delaware’s Statutory Framework
[5.8] Surprisingly, it is controversial to what extent restrictions may be placed
on the authority of directors in a Delaware corporation and how this may be
done. To some extent this uncertainty is the consequence of a statutory drafting
pattern that can be read to create tensions and arguable circularities, perhaps
because the drafters appear in retrospect to have taken too much for granted.
Although the statute reflects the assumption that directors hold power through
conferral by the terms of the statute itself, not through a grant of authority
delegated by shareholders,14 the statute does not always draw clear bounds to
demarcate the allocation of power as between shareholders and directors. Three
13 Kamen v Kemper Fin Servs (7th Cir 1990) 908 F2d 1338 at 1343 (per Easterbrook, J),
rev’d (1991) 500 US 90.
14 See, eg, Unocal Corp v Mesa Petroleum Co (1985) 493 A2d 946 at 953 (“The board has
a large reservoir of authority upon which to draw. Its duties and responsibilities proceed
from the inherent powers conferred by 8 Del C, tit 8 § 141(a), respecting management of the
corporation’s ‘business and affairs.’Additionally, the powers here being exercised derive from
8 Del C § 160(a), conferring broad authority upon a corporation to deal in its own stock.”).
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separate sections of the statute are relevant; two confer power explicitly, while
the other specifies how such conferrals of power may be limited
[5.9] In Quickturn Design, the court went on to say that “any limitation on
the board’s authority” must be set out in the corporation’s certificate of incorporation, the document that when duly filed commences the corporation’s
existence.15 The section of the statute to which the court refers, § 141(a), states
that “[t]he business and affairs of every corporation organised under this chapter
shall be managed by or under the direction of a board of directors, except as
may be otherwise provided in this chapter or in its certificate of incorporation.”
Section 102(b) permits a corporation’s certificate of incorporation to include
“[a]ny provision for the management of the business and for the conduct of the
affairs of the corporation, and any provision defining, limiting and regulating
the powers of the corporation, the directors, and the stockholders....” provided,
however, that “such provisions are not contrary to the laws of this State.” Finally, section 109 provides that shareholders shall have power to adopt, amend,
or repeal by-laws, which may “contain any provision, not inconsistent with law
or with the certificate of incorporation, relating to the business of the corporation, the conduct of its affairs, and its rights or powers or the rights or powers
of its stockholders, directors, officers or employees.” The certificate of incorporation may also (and typically does) confer by-law power on directors, but so
conferring by-law power “shall not divest the stockholders” of their power to
adopt, amend, or repeal by-laws nor limit their power.
15 721

A2d 1291.

10

[5.10] As drafted, these provisions imply limits and priorities that resolve some
initial questions about the import and scope of each. It is also helpful, and
consistent with general conventions of statutory construction, to examine each
discrete section in the context of the statute read as a whole and to attempt to
ascertain a meaning for each section that does not negate the effect of others.
First, to what extent does the statute permit certificate provisions that vary the
statute’s own conferral of powers on directors and shareholders? The conferral of
management authority on directors in section 141(a) is subject to provision otherwise in the corporation’s certificate of incorporation. Section 102(b), which
specifically addresses such provisions, requires that they not be “contrary to
the laws of this State.” This limit should not include the otherwise-complete
conferral of management authority on directors through section 141(a) because
the reference in section 141(a) to limits imposed by certificate provisions would
thereby be read out of the statute. Instead, an example of a certificate provision
“contrary to law” is one that deletes a statutorily-mandated role for directors
or shareholders in connection with a fundamental transaction or event, a category consisting of mergers, sales of all or substantially all of the corporation’s
assets, dissolutions, and amendments to the corporation’s certificate of incorporation. The statutory provisions that define each fundamental transaction or
event and specify how it may be effected require initiation of the transaction
or event through a resolution adopted by a corporation’s directors, followed
by approval by shareholders. These statutory provisions make no reference to
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provision otherwise in a corporation’s certificate of incorporation.16
Despite the frequent references in these provisions to actions taken by shareholders at a meeting, §228 permits shareholders to take effective action without
a meeting, and without prior notice, through a written consent to the action
that is signed by at least the minimum number of holders of outstanding stock
that would be necessary to take action at a meeting at which all outstanding
shares were present and voting. A corporation may elect in its certificate of
incorporation to make § 228 inapplicable. Thus, a certificate provision would
be “contrary to” section 251, which deals with merger transactions, were it to
eliminate the directors’ role of initiation by placing sole authority in shareholders to commit the corporation to a merger transaction. Likewise, a certificate
provision would be “contrary to” section 242, which states how a corporation
may amend its certificate of incorporation, were the certificate provision to confer a unilateral power of amendment on shareholders.
Second, section 141(a) also expressly limits directors’ managerial authority “as
may be otherwise provided in this chapter.” Does this reference encompass
section 109’s grant of by-law power to shareholders? If so, even absent any provision in a corporation’s certificate that limited directors’ management powers,
that power would be subject to binding instructions given by shareholders acting through the vehicle of a by-law. Although a heroic reading of section 141(a)
to this effect enjoys some academic support, its persuasiveness is doubtful. The
reference to “otherwise provided” can be explained more simply and directly as
a reference to provisions elsewhere in the statute that oust directors from managerial authority when an alternate organ of management is appointed, such
16 See Del Code Ann, tit 8, §§ 242(b)(1) (amendment to corporation’s certificate of incorporation requires that board of directors adopt a resolution setting forth proposed amendment,
and vote at shareholder meeting approving amendment by a majority of the outstanding
stock entitled to vote thereon, including approval by majority of outstanding stock entitled
to vote as a class on the amendment); 251 (b) & (c) (merger or consolidation requires that
board of directors of each corporation adopt a resolution approving agreement of merger or
consolidation; agreement must be submitted to shareholder meeting and approved by vote of
majority of outstanding stock entitled to vote thereon, subject to exceptions to requirement
for shareholder approval stated in subsection (f)); 271(a) (corporation may sell, lease, or exchange all or substantially all of its assets on terms set by directors, when and as transaction
is authorised by resolution adopted by holders of majority of outstanding stock entitled to
vote thereon); 275(a) & (b) (corporation may dissolve by resolution adopted “to that effect
by a majority of the whole board” and vote in favor of dissolution at meeting by majority of
outstanding stock entitled to vote thereon).
It is significant that these sections require the affirmative support of a majority of the outstanding stock entitled to vote. Other actions may be taken by shareholders by the affirmative
vote of a majority of the shares present or represented by proxy at a meeting at which a quorum is present. See id § 216. However, directors may be elected by a plurality of votes. Id.
A corporation’s certificate of incorporation or by-laws may prescribe a different number of
shares that shall constitute a quorum, but that number may be no fewer than one-third of
the shares entitled to vote. A corporation may also have a certificate provision that requires a
larger portion of shares, or number of directors, to take any action, see § 102(b)(4); and may
have by-laws that require a greater number of directors than a simple majority to constitute
a quorum or to take action by vote at a meeting, see § 141(b).
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as a receiver.17 Moreover, the heroic reading of section 141(a) ignores the specific treatment of certificate provisions in section 102(b), discussed above. If
shareholders had power to take action at any time in a fashion that reduced directors’ managerial authority, what work is left for certificate provisions to do?
Defenders of the heroic reading of section 141(a) rely on the Delaware cases articulating the “equal dignity doctrine,” the proposition that a transaction validly
effectuated under one section of the statute should not be additionally subject
to requirements applicable under another statutory section that could be used
to effect a transaction that is similar in economic or other respects.18 However,
this doctrine is not applicable unless the transaction is indeed “validly effectuated” under the statutory section defining the transaction, which it would not
be if it did not comply with another section of the statute to which the defining
section made explicit reference; the current dispute instead implicates sections
of the statute that contain express cross-references establishing explicit as well
as implicit hierarchies.19
To some extent, the heroic reading is invited by the structure of section 109
itself. This section confers by-law power on shareholders and permits it to be
conferred on directors as well through a provision in the corporation’s certificate of incorporation. However, section 109 does not prescribe any hierarchy as
between actions taken by shareholders and by directors. Nor does the section
specify any limits on what may constitute a “by-law.” The section grants power
to shareholders and directors that is parallel in scope and effect. Presumably the
corporation’s certificate may prescribe hierarchies to govern otherwise-circular
exercises of the power. If the certificate is silent on the point, section 109’s
explicit parallelism creates the possibility that shareholders may exercise their
power by adopting a by-law, to be followed by action by directors that amends
or repeals the shareholder-adopted bylaw. Indeed, this scenario may follow even
when the shareholder-adopted by-law provides that contrary action by directors
shall be ineffective or specifies circumstances under which the by-law may be
amended or repealed if the directors hold plenary power to “adopt, amend or
repeal” by-laws that is not subject to a limitation imposed by the corporation’s
certificate. Some other states’s statutes expressly address this possibility by
insulating shareholder by-laws from contrary action taken by directors, or by
enabling shareholders to add insulating features to the by-law itself, but the
17 See Del Code Ann, tit 8, §§ 226 (appointment of custodian); 291 (appointment of receiver
for insolvent corporation). Compare Lawrence A Hamermesh, ‘Corporate Democracy and
Stockholder-Adopted By-Laws: Taking Back the Street?’, Tulane L Rev, Vol 73, 1998, pp
409, 430 (“unless otherwise provided by law” should be read to refer to statutory provisions
authorising appointment of custodians, trustees, and receivers who hold managerial authority
in lieu of directors) with Jeffrey N Gordon, “‘Just Say Never?” Poison Pills, Deadhand Pills,
and Shareholder-Adopted Bylaws: An Essay for Warren Buffett’, Cardozo L Rev, Vol 19,
1997, pp 511, 547 (“unless otherwise provided by law” could be read to include shareholder
power created by §109).
18 See Gordon, supra note 17, at 547; Ronald J Gilson, ‘Unocal Fifteen Years Later
(And What We Can Do About It)’, at 24 (June 2000) (unpubl working paper, available
at <http://papers.ssrn.com/paper.taf?abstract id=235417>).
19 See Hamermesh, supra note 17, at 430, n 96.
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Delaware statute does not do so.20
The Statutory Framework for Corporate Law
[5.11] At this point in the analysis, it is important to highlight the significance
of underlying questions about the nature of corporation statutes and their relationship to extra-statutory doctrines. Although these questions do not appear
to have received sustained attention in broader scholarly treatments of the relationship between statutes and the common law, the limited scope of this paper
makes it impossible to examine these questions comprehensively here.21 The
preceding analysis implicitly reflects the view that a contemporary corporation
is a creature of statute, not a common-law artifact. Provisions in the statute
explicitly resolve many points in dispute. However, corporation statutes are
also noteworthy for their omissions. To answer questions and resolve disputes,
counsel and courts necessarily turn to extra-statutory doctrines.
Organisational statutes may be systematically different from other statutes in a
basic way. An organisational statute enables private parties to create a legallyconstituted person with distinct legal personality, which then, acting through
its organs of internal governance (such as a board of directors) or through its
employees and other agents, is empowered to take legally consequential action.
Organisational statutes do not generally attempt to define or regulate such consequences in a wholehearted fashion, for example by supplanting the entirety
of common-law doctrines of agency, contract, and torts. Put differently, even if
corporation law is “largely the preserve of statutes,”22 the legal consequences
of acts done by corporations may fall outside the preserve of the corporation
statute depending on the act and the specific legal consequence.
Organisational statutes may also omit coverage of topics more integral to their
distinctive function. For example, the Delaware statute does not delineate the
duties owed to corporations and shareholders by their directors and controlling
shareholders, in contrast to the Revised Model Business Corporation Act, which
contains a statement of directors’ duties.23 Moreover, neither statute addresses
when a court should disregard a corporation’s separate legal personality and impose individual liability for corporate obligations on shareholders. In contrast,
provisions in some statutes eliminate what would otherwise be an “omission” by
20 For example, the Model Business Corporation Act states explicitly that shareholders may,
in adopting, amending, or repealing a by-law, provide that directors may not amend, repeal,
or reinstate the by-law. Model Bus Corp Act § 10.20(b)(1).
21 For a helpful discussion of general issues, see Jack Beatson, ‘The Role of Statute in the
Development of Common Law Doctrine’, Law Q Rev, Vol 117, 2001, p 247. Professor Beatson’s
article is a searching critique of the view that statutes play no role in the development of the
common law and the corollary view that statutes and codes are fundamentally different.
22 See id at 250.
23 Revised Model Bus Corp Act § 8.30. The Model Act reflects an approach that is “more
directive and ‘bright line”’ with less left to the interstitial work of counsel and courts. This
difference has been explained as “likely less attributable to differences in regulatory philosophy
than to differences in the constituencies for the respective statutes” because states that adopt
the Model Act lack the developed body of precedent resolving difficult questions under the
Delaware statute. Michael P Dooley and Michael D Goldman, ‘Some Comparisons Between
the Model Business Corporation Act and the Delaware General Corporation Law’, Bus Law,
Vol 56, 2001, pp 737, 764-65.
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specifying that the statute’s treatment shall be exclusive in some respect. For
example, under the Revised Model Business Corporation Act, a merger or other
fundamental transaction triggers a statutory right in a shareholder to dissent
and receive a cash payment based on the court’s appraisal of the value of the
shares held by the dissenter. Unlike the Delaware statute, the Model Act provides that those rights constitute the shareholder’s exclusive remedy and that
the transaction may not be challenged except on grounds that are specified by
the statute.24 A court may treat the statute’s exclusivity provision as a source
of principle or policy upon which to draw to resolve a question not expressly
resolved by the statute itself.25
In contrast, questions about the scope of shareholders’ bylaw power do not
involve statutory “omissions” in the sense just discussed because the statute
does not lack the content necessary to answer the questions. Several sections of
the statute, read together, answer the questions. It is not necessary to resort to
extra-statutory doctrines and concepts, like the analogy to common-law agency.
[5.12] As noted above, in the United Kingdom and Australia, the corporation’s
constitution or articles provides the source of directors’ managerial power, not
a direct statutory grant.26 Moreover, the grant of managerial power is more
24 Rev Model Bus Corp Act § 13.02(d). Delaware courts have not implied an exclusivity
provision into the section of the Delaware statute that confers appraisal rights on shareholders.
See Turner v Bernstein (Del Ch June 6, 2000) 2000 WL 776893 at *14. The policy rationale
is it is desirable, when directors seek to argue that a shareholder’s acceptance of merger consideration bars further relief, to place on directors the burden of showing that the stockholder
received “all the information she needed to make a knowing and informed decision.” Id. If the
directors meet this burden, the shareholder loses. If the burden cannot be met, the directors
must defend themselves against claims of breach of fiduciary duty, most likely to be viable if
disloyalty led to the failure to make sufficient disclosure to shareholders. This is a purpose
not served by actions for appraisal. Id.
25 For example, in Galligan v Galligan the corporation did not comply with the notice requirements imposed by the Indiana Business Corporation Law. As a result, the shareholders
did not submit their share certificates and the statutory timetable for an appraisal proceeding
was not triggered. (Ind 2001) 741 NE2d 1217 at 1224. The statute does not specify the
consequences if a corporation fails to initiate the process by notifying shareholders of their
rights. The court held that the corporation’s failure did not entitle shareholders to attack
the underlying merger transaction through an action alleging fraud and breach of fiduciary
duty seeking rescission and possibly punitive damages. The basis for the holding is the court’s
assessment that by providing for an exclusive appraisal remedy, the statute “sought to eliminate the opportunity created by broader decisional law to invoke broader remedies than a
fair valuation of the shares.” Id at 1225. The court thus restricted the shareholders to their
statutory rights to appraisal. The court also recognised the need to provide incentives for
corporations to comply with the statute; if shareholders are unaware of their statutory rights,
they may be relegated to a “legal limbo” or be put to a significant expense not contemplated
by the statute. Accordingly, the court held that the shareholders had a separate claim against
persons responsible for the corporation’s breach of statutory duty, for which the remedy could
include losses stemming from delay, as well as any loss based on impairment of the corporation’s financial capacity to make full payment of the appraised value, when the delay led to
the impairment. Id at 1225-26.
26 For Australia, see Corporations Law § 226A(1) (replaceable rule that “the business of
the company is to be managed by or under the direction of the directors.”). For the United
Kingdom, see Companies Act 1985 § 8(1) (company may adopt for its articles the whole or any
part of Table A) & Table A, art 70 (“Subject to the provisions of the Act, the memorandum
and the articles and to any directions given by special resolution, the business of the company
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fragile than in a Delaware corporation because corporations legislation in the
United Kingdom and Australia confers on shareholders the unilateral power to
amend the corporation’s articles or constitution.27 In contrast, as noted above
[5.10] in a Delaware corporation, amendments to a certificate of incorporation
require a resolution adopted by the board of directors as well as adoption by
shareholders.
Thus, UK and Australian law deals shareholders a stronger hand, one strengthened by the power to remove directors by majority vote without showing cause
for removal.28 This leverage does not, however, translate into the power to give
binding instructions to directors separate from the mechanisms of constitutional
amendment.29 Since early in the twentieth century, it has been assumed that,
although shareholders may amend a corporation’s articles, “where powers had
been vested in the board, the general meeting could not interfere with their
exercise.”30 To be sure, the line between constitutional amendment and interim
interference with the exercise of managerial power may not be clear. A recent
illustration is NRMA, Ltd v Snodgrass, in which the court held that members of
an Australian company had power to vote at a general meeting on a proposed
amendment to the company’s constitution requiring the company to reimburse a
member for legal costs he incurred in an earlier battle with the company.31 The
court characterised the provision as “strange,”“unusual,” and “in some ways
perhaps. . . undesirable,” but not invalid as a restriction on the management
power otherwise vested in the company’s directors.32
The Current Take-over Context
[5.13] Until recently, the significance of these points of statutory construction
fell below the radar screens of both academic commentary and litigated controversy in the United States. As in NMRA v Snodgrass, one exception consisted of
periodic disputes about whether proposals initiated by shareholders concerned
matters that were not proper subjects for action by shareholders or fell within
the category of “ordinary business.” If so, the SEC’s proxy rules permit the
corporation to exclude the proposal from the proxy statement that public corporations must send to shareholders prior to their annual meeting.33 These
shall be managed by the directors who may exercise all the powers of the company”).
27 Corporations Law § 136(2) (special resolution may alter constitution); Companies Act
1985 § 9 (special resolution may alter articles). A special resolution requires the support of
holders of 75 per cent of the shares entitled to vote. See Corporations Law § 9; Companies
Act § 378(2).
28 See Corporations Law § 227 (notwithstanding anything in corporation’s articles or constitution, shareholders of public company may remove any director or directors through an
ordinary resolution); Companies Act 1985 § 303 (notwithstanding anything in its articles or
in an agreement with a director, a company may by ordinary resolution remove a director).
29 See Automatic Self-Cleansing Filter Syndicate Co v Cunninghame [1906] 2 Ch 34.
30 See Paul L Davies, Gower’s Principles of Modern Company Law 183 (6th ed 1997).
Table A’s Article 70 may not be entirely consistent with the caselaw because it appears to
make the directors’ exercise of management power subject to “any directions given by special
resolution. . . .” To harmonise this provision with the caselaw, one would read it to address
only directions curtailing power that directors may exercise in the future. Id at 185-86.
31 NRMA, Ltd v Snodgrass [2001] NSWSC 76.
32 Id at ¶ 13.
33 Judicial opinions as well as administrative determinations by the SEC and its staff inter-
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disputes did not, however, focus sustained attention on whether the statutory
grant of by-power to shareholders empowers them to give binding instructions
to directors. Instead, the question acquired its current salience as a consequence
of how the structure of contested take-overs evolved.
[5.14] In contrast to UK take-over regulation, described below [5.20-.21], the
applicable body of Delaware doctrine allocates a greater measure of unilateral
discretion to directors of a target corporation to adopt measures that frustrate
a bid the directors believe to be contrary to the interest of the corporation or its
shareholders. Take-over defenses that involve an alternate transaction, such as a
debt-funded restructuring of the target34 or the acquisition of another corporation35 may carry enduring financial and operational consequences for the target.
These consequences explain the attractiveness of an alternate defensive tactic,
within the unilateral control of directors, that does not necessarily entail these
consequences. The “poison pill” works well in this respect. Specifically legitimated by the Delaware Supreme Court in 1985,36 the poison pill is an instance
of creative ingenuity brought to bear by corporate lawyers.37 A poison pill consists of rights issued to a corporation’s shareholders that entitle the holder of
an issued right, upon the occurrence of specified trigger conditions, to purchase
shares on bargain terms. If a poison pill has a “flip-in” feature, the shares that
may be purchased are shares of the corporation that issued the purchase rights.
If the pill has a “flip-over” feature, the purchase rights apply to shares of another corporation, for example a corporation that buys a stated percentage of
shares in the corporation that issued the rights and subsequently proposes to
merge with it. Although it is counter-intuitive that a corporation would have
power to issue rights that create entitlements to acquire shares in another corporation, the power can be analogised to features of convertible debentures that
protect the holder against the destruction of value in the event of subsequent
transactions by creating exchange rights.38 As a defensive tactic, a poison pill
pret the meaning of these concepts. On these developments, see, eg, Carol Goforth, ‘Proxy
Reforms As a Means of Increasing Shareholder Participation in Corporate Governance: Too
Little But Not Too Late’, Am UL Rev, Vol 43, 1994, p 379; Stewart J Schwab & Randall S
Thomas, ‘Realigning Corporate Governance: Shareholder Activism By Labor Unions’, Mich
L Rev, Vol 96, 1998, p 1018.
34 See, eg, Unocal Corp 493 A2d at 950 (defensive transaction consisting of self-tender
offer to exchange equity for senior debt securities would require target corporation to reduce
exploratory drilling due to incurrence of over $6 billion in additional debt).
35 See, eg, Paramount Communications, Inc v Time, Inc (Del 1990) 571 A2d 1140 at 1148
(target acquired stock of preferred merger partner through cash tender offer that required
incurrence of $7-10 billion in additional debt).
36 See Moran v Household Int’l, Inc (Del 1985) 500 A2d 1346.
37 Credit for the invention is commonly given to the New York law firm of Wachtell, Lipton,
Rosen & Katz. See John C Coates IV, ‘Takeover Defenses in the Shadow of the Pill: A
Critique of the Scientific Evidence’, Tex L Rev, Vol 79, 2000, pp 271, 271 n*.
38 See Moran 500 A2d at 1352. In particular, debt and preferred equity securities that are
convertible into common stock often contain “anti-destruction” clauses that, in the event of
a merger transaction that will eliminate the stock of the issuing company, permit holders of
the convertible securities to convert into the securities that will replace the stock of the issuer
if the merger is effected. See, eg, Broad v Rockwell Int’l Corp (5th Cir 1981) 642 F2d 929 at
946. When an indenture or certificate designating the rights of preferred stock does not create
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is effective because, if triggered, the pill creates the risk of substantial dilution,
either of the target’s equity or that of a hostile bidder.
The unilateral discretion that Delaware invests in directors in this context is
not unlimited, however. Directors may not adopt a pill that is not redeemable
because their fiduciary duties require that they be able to assess the interests of
the corporation and its shareholders as against particular take-over proposals.
Adopting a non-redeemable pill would eliminate the directors’ ability to permit
a bid to proceed if its terms are attractive by redeeming the pill and the threat
of dilution it poses.39 Whether to redeem a pill is a decision within the province
of the target directors’ business judgment, subject to the specific showing described below.
Moreover, the widespread adoption of poison pills stimulated the creative ingenuity of hostile bidders and their legal counsel. For example, a bidder might
expressly make its bid subject to the condition that the target’s directors redeem a poison pill they previously adopted. Many prospective bidders took an
alternate route, which was to solicit proxies from shareholders to remove the
corporation’s incumbent directors and elect designated successors to the board,
who could then redeem the pill.
[5.15] As a response, some poison pills were structured with a “dead-hand” feature, which disqualified directors from voting to redeem the pill unless they were
directors when the pill was adopted or unless their election to the board was
recommended or approved by the continuing directors. Delaware cases in the
late-1990’s invalidated “dead-hand” poison pills and pills that were expressly
non-redeemable for any period of time.40 Carmody v Toll Brothers, Inc held
that a dead-hand feature impermissibly restricts the powers of newly-elected
directors in the absence of any provision in the corporation’s certificate prescribing such restrictions or discriminating among directors in the powers that
directors shall hold.41 Additionally, a dead-hand pill restricts the efficacy of
such a right of conversion, courts decline to imply one. See id.
39 Moran, which legitimates the adoption of poison pills, also states explicitly that directors
may not “arbitrarily” reject a request to redeem a pill so that a hostile bid may be made.
See 500 A2d at 1354. Instead, “[t]hey will be held to the same fiduciary standards any other
board of directors would be held to in deciding to adopt a defensive mechanism, the same
standard as they were held to originally in approving the Rights Plan.” Id. In Quickturn
Design, the court specifically held invalid a provision in a poison pill that delayed the ability
of a newly-elected board to redeem it by six months. See 721 A2d at 1292.
40 The reaction in three other states is more hospitable to aggressively-structured poison
pills. See AMP Inc v Allied Signal, Inc (ED Pa 1998) 1998 WL 778348 at *6 (upholding
nonredeemable poison pill under Pennsylvania law), rev’d on other grounds, (3d Cir 1999)
168 F3d 649; Invacare Corp v Healthdyne Techs, Inc (ND Ga 1977) 968 F Supp 1578 at
1580 (upholding dead-hand poison pill under Georgia law); Md Code Ann Corps & Ass’ns
§ 2-201(c)(2)(ii) (1999) (authorising adoption of poison pill with nonredeemability provision
limited to 180 days). In contrast, a form of deadhand pill was invalidated under New York
law in 1988. See Bank of New York v Irving Bank Corp (Sup Ct 1988) 528 NYS2d 482 at 485
(invalidating poison pill because it discriminated, in the absence of a basis in the statute or the
corporation’s certificate of incorporation, between, on the one hand, continuing directors and
directors elected by a super-majority vote of shareholders, and, on the other hand, directors
validly elected by a plurality of votes cast).
41 Carmody v Toll Bros, Inc (Del Ch 1998) 723 A2d 1180 at 1191-92.
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the shareholders’ voting franchise by coercing shareholders into voting for the
incumbents, or candidates endorsed by the incumbents, when shareholders are
inclined to vote otherwise.42
[5.16] As a consequence of these strategic moves, counter-moves, and judicial
responses, hostile bidders may overcome intransigent opposition by a target’s
directors by mounting a proxy solicitation to elect new directors, who, once
elected, may vote to redeem a poison pill. Moreover, Delaware cases insulate the shareholders’ voting franchise from measures taken by directors that
would thwart its efficacy. In Blasisus Industries, Inc v Atlas Corp, the Court of
Chancery held that directors may not take steps to thwart a shareholder vote
unless the directors can demonstrate a “compelling justification.”43 In Blasius
itself, the target’s directors responded to the delivery of a form of stockholder
consent by a 9 per cent shareholder that, if joined in by holders of a majority
of the stock, would increase number of directors on the board from seven to
fifteen, which was the maximum number authorised by the target’s certificate.
The directors responded by adding two new directors to the board, which if
effective would thwart the ability of a majority of the shares to elect a new
majority to the board because, for reasons explained below [5.17], a majority of
the shares would presumably have been unable to remove the incumbent directors.44 Interestingly, the court conceded in Blasius that the directors may have
acted in good faith because the 9 per cent shareholder’s announced plan for
the corporation consisted of an aggressively-structured leveraged restructuring
that, if implemented, would in the opinion of the corporation’s financial advisor
leave the corporation with no chance of repaying its debt. However, the court
held that the directors failed to satisfy the “compelling justification” standard
because the corporation’s shareholders “could view the matter differently than
did the board. If they do, or did, they are entitled to employ the mechanisms
of the corporation law and the. . . certificate of incorporation to advance that
view.”45
[5.17] In short, although Delaware cases empower directors to take unilateral
measures that may thwart hostile take-overs, their power is subject to shareholders’ power, insulated by cases like Blasius , to elect new directors. This
resolution, in the view of a prominent academic commentator, reflects a preference for elections over markets as a mechanism for resolving contests for corporate control.46 Of course, the contemporary corporate form itself means that
shareholders do not act by simple fiat, unlike principals in a relationship of
common-law agency; shareholder action, regardless of its subject, requires a
mechanism for collective action, such as voting at a meeting or signing a written consent like that proposed in Blasius. Other patterns of takeover regulation,
42 Id

at 1193-94.
Ch 1988) 564 A2d 651 at 661.
44 Directors on the target’s board were elected for staggered terms, which under Del Code
Ann § 141(k)(1) would require a showing of cause to effect removal. See 564 A2d at 655.
45 Id at 663.
46 See Gilson, supra note 18, at 2 (Delaware cases, beginning with Unocal, have developed
“into an unexplained and, I think, inexplicable preference that control contests be resolved
through elections rather than market transactions.”).
43 (Del
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discussed below, subject directors’s defensive responses to hostile takeovers to
a shareholder vote to ascertain approval or disapproval of the specific response,
whereas Delaware confines shareholder power to choosing directors unless the
statute or the corporation’s certificate require otherwise.
As it happens, the proxy-fight route is potentially fraught with difficulty. Delaware
permits directors to be elected for staggered terms as long as three years, and
unless a corporation’s certificate of incorporation expressly provides otherwise,
directors on a staggered or “classified” board are not removable by a shareholder
vote except upon a showing of cause.47 Under the cases defining “cause,” which
admittedly are sparse, simple disagreement with fellow directors or with senior
management does not constitute grounds for removal.48 It is highly unlikely
that disagreeing with a majority of the shareholders would constitute grounds
for removal, either.49 Thus, it may take two annual elections to elect a probidder majority to the board, unless the carry-over directors resign, which they
may well determine to do.50 In the meantime, tensions between the incumbent
directors and their new colleagues may be substantial. Additionally, the target corporation may attract the interest of another acquiror who offers to pay
more than the initial bidder, or otherwise offers terms more attractive to the
hold-over directors, who may redeem the poison pill in a manner that permits
an acquisition by the favored party but not the initial bidder.51
Thus, it is not surprising that attention is now focused on the potential that
shareholder-adopted by-laws may hold to overcome the ability of incumbent directors effectively to frustrate all but a determined bidder, especially when the
directors on a corporation’s board are insulated from removal except upon a
showing of cause. Shareholder-adopted by-laws hold out the promise of affirmative and determinative action that shareholders may take, as opposed to the
route of electing new directors, which one academic commentator characterises
47 Del Code Ann, tit 8, § 141(k) (ii). Under § 141(d), a board may be classified by a
provision in the corporation’s certificate of incorporation, by an initial by-law, or by a bylaw adopted by a vote of shareholders. Classifying the board through a by-law adopted only
by the corporation’s directors is not an option. In contrast, Maryland recently amended its
corporation statute to permit directors to classify the board so long as the board so acting has
at least three independent members. See Md Code Ann Corps & Assn’s § 3-801(1999). As
amended, the Maryland statute also authorises the adoption of poison pills with dead-hand
features that are limited to 180 days. See id § 2-201(c)(2)(ii)(1999).
48 The leading case is Campbell v Loew’s, Inc (Del 1957) 136A2d 191.
49 To treat disagreement with a majority shareholder as cause for removal would undercut the
ability of directors to discharge their fiduciary duties to all of the corporation’s shareholders,
including minority or noncontrolling shareholders.
50 Prior to the invention of the poison pill, directors on classified boards resigned from office
once a bidder acquired majority stock ownership. See Coates, supra note 37, at 326, n 214
& 329 n 227; Ronald J Gilson, ‘The Case Against Shark Repellent Amendments: Structural
Limitations on the Enabling Concept’, Stan L Rev, Vol 34, 1982, 775, 780. These sources do
not address whether target directors in fact resigned less frequently once poison pills became
widespread.
51 See John C. Coffee, Jr., ‘The Bylaw Battlefield: Can Institutions Change the Outcome
of Corporate Control Contests’, U Miami L Rev, Vol 51, 1997, pp 605, 606. This presumably
is an outcome that the target’s shareholders might favor, but the risk of its occurrence could
deter some initial bidders.
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as “essentially reactive and contingent.”52
What is a by-law and what may it do?
[5.18] Section 109 (b) in the Delaware state, like its counterpart provisions in
other corporation statutes, deals in general terms with the permissible contents
of by-laws: a corporation’s by-laws may contain any provision not inconsistent
with law or with the corporation’s certificate of incorporation “relating to the
business of the corporation, the conduct of its affairs, and its rights or powers or
the rights or powers of its stockholders, directors, officers or employees.” Other
sections of the statute explicitly contemplate the use of by-laws as vehicles by
which to take specific actions. These including fixing the number and qualifications of directors, prescribing how officers shall be chosen and the terms of their
offices, creating rights to indemnification, designating how the date and time of
the annual shareholder meeting shall be determined, and designating authority
to call special meetings of shareholders.53 Other sections of the statute may
be read to impose implicit limits on the potential scope of by-laws permitted
by § 109(b) because they explicitly require that a matter be addressed in the
corporation’s certificate of incorporation. These include stating the business or
purpose for which a corporation has been organised, requiring that action by
shareholders be taken at a meeting in contrast to a written consent signed by
holders of a majority of shares, and permitting removal of directors without a
showing of cause when a board of directors has been classified.54 One might,
then, limit the scope of permissible by-laws under §109(b) to those matters that
the statute elsewhere links to resolution through a by-law.55 This carries the
functional consequence that, although shareholders may adopt by-laws dealing
with many procedural matters, they lack power to adopt by-laws that bind
directors as to matters otherwise within the scope of the directors’ general managerial authority.
[5.19] The sole reported case involving a shareholder-adopted by-law and a contested poison pill, International Brotherhood of Teamsters General Fund v Fleming Cos, held that shareholders in an Oklahoma corporation had power to adopt
a by-law providing that the corporation may not adopt or maintain a poison pill
without prior consent and that any pill presently in force must be redeemed.56
The Teamsters apparently initiated the by-law campaign after 65% of Fleming’s
shares were voted in favor of a nonbinding resolution providing that the board
should not adopt a poison pill without receiving prior assent from sharehold52 Id

at 605.
Del Code Ann, tit 8, §§ 141(a) (number of directors and qualifications of directors);
141(b) (manner of choosing officers and terms of office); 211(a) (date and time for annual
meeting of shareholders); 141(d) (specifying person with authority to call special meeting of
shareholders).
54 See id §§ 102(a)(3) (nature of business or purposes to be conducted or promoted by corporation); 228(a) (action that may be taken at meeting of shareholders may be taken by signed
consent unless otherwise provided in certificate of incorporation); 141(k) (shareholders may
effect removal of directors on classified board only for cause unless certificate of incorporation
provides otherwise).
55 This is consistent with the limits on by-laws suggested in Hamermesh, supra note 17, at
480. The alternative is to specify functional limits, as is suggested in Coffee, supra note 51.
56 (Okla 1999) 975 P2d 907.
53 See
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ers.57 Although the court notes that shareholders’ role in corporate governance
is “purposefully indirect,” it locates a source of direct power for shareholders
in cases and statutes that permit or require shareholders to approve the adoption of stock option plans, for example to cure the adoption of a plan by an
interested board of directors. The court also notes that while some states have
by statute expressly endorsed directors’ authority unilaterally to adopt poison
pills, Oklahoma has not done so.
Although Oklahoma’s corporations statute bears close resemblance to Delaware’s,
the Fleming opinion should not be persuasive to a court applying Delaware law.
For starters, the Delaware Supreme Court upheld directors’ unilateral authority
to adopt poison pills in the absence of an explicit conferral of specific statutory
authority. Perhaps more important, the reasoning in Fleming is inconsistent
with the implications of the analytic starting-point in many Delaware opinions,
which is that the statute confers managerial authority on directors subject solely
to restrictions imposed by the statute itself and corporation’s certificate of incorporation. Amending the certificate is not an action shareholders may take
unilaterally because the statute requires that a certificate amendment originate
with a resolution adopted by directors.58
A comparative perspective on basic structural choices
[5.20] Viewed in somewhat broader perspective, these questions are inevitable
consequences of basic structural features of the allocation of power as between
a target’s shareholders and its directors in the context of a hostile take-over.
Delaware cases, most notably Unocal Corp v Mesa Petroleum Co in 1985, recognise that the target’s directors are in a position of “inherent conflict” because
they must, on the one hand, exercise business judgment to determine whether
a pending takeover is in the best interests of the corporation and its shareholders while, on the other hand, facing temptations to act primarily in their
own interests, for example to preserve their own positions.59 As a consequence,
these cases require directors to bear the burden of showing that they acted in
good faith and on the basis of a reasonable investigation to respond to a perceived threat to the corporation. Directors must also be able to establish that
the action taken was reasonable, proportionate to the perceived threat, and
not “draconian.”60 If the target’s directors make these threshold showings, the
court does not further assess the merits of their decision and treats the decision
57 See

Coffee, supra note 51, at 605, n 2.
Code Ann, tit 8, § 242(b)(1).
59 See 493 A2d at 955.
60 Id at 955-56. The court defined “draconian” in Unitrin Inc v American General Corp
(Del 1995) 651 A2d 1361 at 1383-88 as a defensive measure that has the effect either of
coercing shareholders or of precluding a proxy fight. If a defensive measure has neither effect,
the court’s focus is upon whether the measure falls within a range of reasonableness. Id.
The standard of review shifts if a target’s directors initiates a process to sell the corporation
or that will lead to its break-up, or if sale or break-up otherwise becomes inevitable. The
target’s directors must then justify the actions they take against a criterion of maximising the
value to be received by shareholders. See Revlon, Inc v MacAndrews & Forbes Holdings, Inc
(Del 1986) 506 A2d 173 at 182. In contrast, Unocal explicitly permits the board to consider
interests in addition to those of shareholders, including “creditors, customers, employees, and
perhaps even the community generally. . . .” 493 A2d at 955.
58 Del
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as an exercise of the directors’ business judgment. Conduct by target directors
that does not satisfy these standards may culminate in a contract with a third
party, typically an acquisition partner that is preferred by the target’s directors.
Contract rights acquired by the third party are unenforceable when they stem
from breaches of fiduciary duty by the target’s directors. Likewise, a third-party
contract is invalid to the extend it purports to limit the target directors’ fiduciary duties.61
Alternate structural choices are possible, of course, and it is illuminating to consider the system of take-over regulation in the United Kingdom in contrast to
Delaware. The City Code on Mergers and Take-Overs, applicable to public companies, like Delaware allocates initial managerial control to a target’s directors
by requiring that an offer be put in the first instance to the offeree’s board or to
its advisers.62 The board must obtain the advice of independent advisers63 and
must circulate its own assessment of the bid to the shareholders along with the
substance of the advice it has received from its independent advisers.64 Beyond
that point, however, the City Code and Delaware diverge. Under the City Code,
after a bona fide offer has been communicated to the board, or once the board
has reason to believe that such an offer might be imminent, the board may not
take action that could “effectively result in any bona fide offer being frustrated
or in the shareholders being denied an opportunity to decide on its merits.”65
The target’s directors may, however, take action that could frustrate a pending
or imminent bid if they obtain the shareholders’ approval, expressed through a
resolution adopted by majority vote at a shareholders’ meeting.66 The Code’s
position is consistent with prior cases. For example, in Hogg v Cramphorn, in
the face of a pending take-over bid, the target’s directors issued a large block of
shares to a trust created for the benefit of employees.67 The court held that the
61 See Paramount Communications, Inc v QVC Network, Inc (Del 1993) 637 A2d 34 at
51. In this case, the target’s directors agreed to pay their preferred acquisition partner a
termination fee of $100 million if another party acquired the target, as well as granting a
put option to the preferred acquisition partner that entitled it to an amount of cash equal to
difference between the purchase price as set by the deal and the market value of target’s stock.
The put option attained a value of around $500 million due to a hostile bid at a higher price.
The court held that the preferred acquisition partner had not acquired enforceable contract
rights because the option was part of an unreasonable and “draconian” defensive package. Id.
The court also held that terms in the contract with the preferred merger partner, including
a no-shop clause, were unenforceable because they purported to limit the target directors’
ability to discharge their fiduciary duties. See id. See also Revlon, 506 A2d at 184 (affirming
lower court’s injunction prohibiting target from paying $25 million cancellation fee to preferred
acquisition partner in face of hostile bid at higher price).
62 City Code on Takeovers and Mergers, Rule 1.
63 Id, Rule 3.1.
64 Id, Rule 25.1.
65 Id, General Principle 7.
66 Id, General Principal 7.
67 [1967] Ch 254. The directors also allocated 10 votes per share to the shares issued to the
trust, which the court held to be without effect because the company’s articles did not give the
directors power to issue shares carrying more than one vote per share. It has been suggested
that directors who fail to respect limits on their powers do not breach a fiduciary obligation.
See Paul L Davies , Gower’s Principles of Modern Company Law 605 (6th ed 1997). In
contrast, a recent Delaware opinion holds that directors breached their fiduciary duties by
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share issuance was voidable because the directors acted for an improper purpose
but that the directors’ action could be ratified by a majority of the pre-issuance
shareholders.68
[5.21] But the City Code does not leave directors bereft of
defensive resources. The City Code rule itself does not reach measures taken
by directors prior to the emergence or imminence of a concrete bid,69 nor does
it prohibit directors from informing shareholders that if they reject the bid, the
directors will take a stated action, such as selling assets and distributing the
proceeds to the shareholders. Finally, in submitting a proposed defensive measure to shareholders, directors have tactical advantages, including control over
the corporation’s proxy machinery and the date of the meeting.70
Despite these tactical advantages, target directors subject to the City Code
lack unilateral power to the degree held by their counterparts in a Delaware
corporation because the Code essentially requires transaction-specific approval
of defenses by the target’s shareholders once a hostile bid has been made or
reasonably appears imminent. The need for shareholder approval operates as a
constraining force on the defensive proposals that the directors of any particular target are likely to advance. The restraints imposed by the Code parallel
the basic structural feature of UK company law that allocates to shareholders
control over the corporation’s constitution, including control over the definition
of directors’ powers. Nonetheless, the Code does not grant shareholders the
interim powers of initiative and direction that would typify a principal in an
agency relationship. The Code, like cases treating directors’ actions as voidable, casts shareholders in a reactive role, one in which decisions and actions
are necessarily confined by the action that directors propose to take, as opposed
to the active and initiatory role entailed in drafting by-laws and other mandates
that directors must implement.71
[5.22] In Australia, unlike the United Kingdom, the constraints on target directors continue to be derived from general limits on the fiduciary position held by
directors. The significance of these limits has not been developed in case-bycase litigation comparable in extent to the Delaware material canvassed above.
awarding more shares to executives than were authorised by the terms of a plan approved
by shareholders. See Sanders v Wang (Del Ch, Nov 8, 1999) 1999 WL 1044880 (holding
that complaint stated claims for gross negligence, waste of corporate assets, and breach of
fiduciary duty; plaintiff sought remedies including rescission, imposition of constructive trust,
and damages for any losses incurred by corporation).
68 When a the company held a shareholder meeting, the shareholders approved the share
issuance. This led the court to dismiss the objecting shareholder’s action.
69 For a comprehensive treatment of pre-bid defensive measures, see Weinberg and Blank on
Takeovers and Mergers at § 4-7063 to 4-7093 (Lawrence Rabinowitz, ed) (5th ed 2000).
70 Id at § 4-7096.
71 To similar but not identical effect, the Toronto Stock Exchange has a requirement for listing that compels the withdrawal of a poison pill unless shareholders approve within six months
after the board adopts the pill. See Hamermesh, supra note 17, at 442 n 141; Toronto Stock
Exchange Company Manual, Appendix G, in Victor P Alboini, Securities Law and Practice
Vol 10 (1984 & 2000 Supp). This specific requirement is based on a broader stock exchange
rule that gives the exchange discretion to require shareholder approval when a transaction “is
of such a nature as to make shareholder approval desirable, having regard to the interests of
the company’s shareholders and the investing public.” Id § 606(c).
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To some degree, this may be the consequence of differences in the underlying
corporations legislation imposing categorical limits on directors’ authority; for
example, a selective buy-back of shares requires shareholder approval, which it
would not under the Delaware statute.72 The fundamental principle is that directors may not use their discretionary powers for other than proper purposes.
Whether directors acted for one purpose as opposed to another is a question of
fact that turns on the directors’ subjective beliefs about why they took a particular action.73 However, a purpose that is proper does not become improper
if it carries the incidental consequence of frustrating an imminent take-over bid.
Thus, Australian cases uphold defensive transactions when directors can justify
then by reference to the corporation’s commercial interests.74 Additionally, a
corporation, acting though its directors, may have a legitimate interest in the
identity of its shareholders and in the circumstances under which it may be able
to raise capital in the future.75 If, as would often be the case, directors act for
multiple purposes, one of them improper, the question is whether the improper
purpose dominated in that, had it not been present, the directors would not
have acted as they did.76
Ratification and exoneration of directors
[5.23] The basic distinction developed in this paper is also relevant to understanding why corporate law, at least in the United States, imposes limits on
extent to which shareholders may, by a majority vote, exonerate directors from
claims of breach of duty. Although it is helpful to distinguish among types
of claims that shareholders may assert, the lines of analytic demarcation tend
to merge when directors take action that that affects control of a corporation.
Consider first a claim that a transaction constituted a waste of the corporation’s
assets. This is a doctrine developed most fully in recent cases contesting the
terms of executive compensation. As recently defined by the Delaware Supreme
Court, “waste” occurs when directors “irrationally squander or give away corporate assets.” A transaction does not constitute waste when the corporation
receives any substantial consideration in exchange and “if there is a good faith
judgment that in the circumstances the transaction is worthwhile....”77 The dis72 See Corporations Law Pt 2J.1; Ford, Austin & Ramsay, supra note 10, at 1173-82. Section
160(a) in the Delaware statute empowers a corporation to purchase or otherwise acquire its
own securities. A corporation may not purchase or redeem its own shares when its capital is
impaired or when the result of the transaction would be an impairment of capital. See Del
Code Ann, tit 8, § 160(a)(1). The Delaware statute does not require a corporation to cancel
or retire shares that it has repurchased, in contrast to the Australian requirement, see Ford,
Austin & Ramsay, supra note 10, at 1177, but repurchased shares that the corporation holds
are not entitled to vote and may not be counted for quorum purposes, see Del Code Ann, tit
8, § 160(c).
73 See Howard Smith Ltd v Ampol Petroleum Ltd [1974] AC 821.
74 See, eg, Pine Vale Investments Ltd v McDonnell & East Ltd (1983) 8 ACLR 199, 1 ACLC
1294.
75 See Darvall v North Sydney Brick & Tile Co (1989) 16 NSWLR 260 (Ct App).
76 See Whitehouse v Carlton Hotel Pty Ltd (1987) 162 CLR 285 at 294. As a consequence,
“[t]here seems to be no escape for the tribunal of fact from the difficult task of deciding
whether one of a number of purposes can be taken to have been more important than others
in the minds of the directors.” Ford, Austin & Ramsay, supra note 10, at 336.
77 Brehm v Eisner (Del 2000) 746 A2d 244 at 263.
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positive question is whether “no business person of ordinary, sound judgment
could conclude that the corporation received adequate consideration.”78 The
vote of a majority of a corporation’s shareholders is not effective to ratify waste
or to exonerate directors from claims arising from a wasteful transaction.79 Only
through a unanimous vote may shareholders ratify waste.80 The rationale given
for this position in Lewis v Vogelstein is that waste “constitutes a gift of corporate property and no one should be forced against their will to make a gift of
their property.”81
What’s puzzling about this rationale is that the Delaware statute explicitly empowers corporations to make gifts of their property for stated purposes, a power
that directors may exercise without shareholder assent unless the certificate of
incorporation requires shareholder assent.82 This puzzle can be resolved if scenarios that constitute waste are viewed as ones in which directors are no longer
exercising authority on behalf of the corporation. Instead, directors who commit the corporation to a transaction that constitutes waste act as co-agents on
behalf of a group of co-principals – the corporations’ shareholders– thus making
the consent of each co-principal necessary. Thus, in Lewis v Vogelstein, quoted
above, the court referred to “their” property, that belonging to shareholders.
Similarly, shareholders are deemed to be co-principals (albeit not explicitly so)
by the court’s resolution in Sanders v Wang, in which a corporation’s directors
issued shares in excess of the number previously authorised by the shareholders in voting to approve the specifics of an executive compensation plan. The
court held the that the unauthorised issuance constituted waste because the
corporation received no consideration in exchange when it issued the additional
shares.83 By treating shareholders as co-principals, at least in this limited respect, the waste doctrine necessarily carves out an exception to the majoritarian
rule otherwise applicable to shareholders’ decisions, an exception that is not satisfied even if the majority vote follows ample disclosure of information.84
[5.24] In contrast, Delaware cases recognise that the vote of a majority of a corporation’s shareholders may be effective to exonerate directors from claims of
78 Id.
79 See

Lewis v Vogelstein (Del Ch 1997) 699 A2d 327 at 335.
Saxe v Brady (Del Ch 1962) 184 A2d 602 at 605.
81 See Lewis v Vogelstein 699 A2d at 335-36.
82 See Del Code Ann, tit 8, § 122(9)(providing that every corporation incorporated under
statute shall have power to “[m]ake donations for the public welfare or for charitable, scientific
or educational purposes, and in time of war or other national emergency in aid thereof”).
See also Sarah Worthington, ‘Corporate Governance: Remedying and Ratifying Directors’
Breaches’, LQR, Vol 116, 2000, pp 638, 672 (noting that “[a] company can give away its
assets, provided that the decision is taken for proper purposes and does not contradict any
express restrictions in the company’s constitution. The company will be doing exactly this
whenever it decides to exonerate its defaulting directors. . . . In principle a company ought
to be able to exonerate its directors for any breach of fiduciary duties.”).
83 (Del Ch, Nov 8, 1999) 1999 WL 1044880.
84 But see Harbor Fin Partners v Huizenga (Del Ch 1999) 751 A2d 879 at 897-98 (arguing that waste doctrine is unnecessary to protect shareholders because “where disinterested
shareholders are given the information necessary to decide whether a transaction is beneficial
to the corporation or wasteful to it, I see little reason to leave the door open for a judicial
reconsideration of the matter”).
80 See
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negligence or gross negligence that result from a failure to use due care.85 The
shareholder vote will not have this effect unless it is informed.86 Directors who
act incompetently or carelessly still act on behalf of the corporation, making
relevant the shareholders’ power to act collectively by a majority vote.
The question of exoneration arises in the context of contested take-over transactions if a majority of a target’s shareholders vote to approve a defensive transaction proposed by directors who arguably breached the duties outlined above.87
Delaware cases decline to find that a shareholder vote exonerates the directors.
The rationale is that permitting majority shareholder approval in this context
would legitimate action by the board that coerces a minority of the shareholders
into assenting to an unwelcome transaction, one perhaps “draconian” under the
standards explored above.88 It is relevant that the board itself is the author of
the transaction in question and in a strategic position to shape how the transaction is presented to the shareholders for approval.89 Analogously, a principal
in a relationship of common-law agency is not bound by a ratification induced
by an agent’s misrepresentation or other conduct that would make a contract
voidable, such as duress.90 A minority of shareholders, likewise, should not be
deprived of claims on the basis of the assent of a majority of shareholders when
what is assented to is itself coercive of shareholder decision-making or preclusive
of the effective exercise of the voting franchise to elect new directors.
Other considerations
[5.25] Thus far the analysis in this paper has not ventured beyond the analytic
precincts defined by statutory language and structures, common-law doctrines,
and settled precedent. One reason for caution in venturing beyond these formal
confines is that several key empirical questions remain unanswered, making it
difficult to assess what consequences might follow were shareholders to be empowered to adopt by-laws regulating the adoption of poison pills or instructing
directors to redeem them. For example, it is open to active dispute whether on
balance shareholders are injured by the adoption of poison pills. With the exception of one early event study that identified a relatively small negative effect
on shareholder wealth when directors adopted a poison pill, most studies have
85 See,

eg, Smith v VanGorkom (Del 1985) 488 A2d 858 at 889.
id.
87 See In re Santa Fe Pac Corp Shareholder Litig (Del 1995) 669 A2d 59 at 68; cf In re
Wheelabrator Techs Shareholder Litig (Del Ch 1995) 663 A2d 1194 at 1202-03 (explaining
that operative effect of shareholder approval is either to shift the burden to the plaintiff of
establishing that a transaction was not entirely fair or to shift the standard of review to
whether directors exercised business judgment; under Delaware cases shareholder approval
exonerated directors only against claims of failure to exercise due care prior to committing
corporation to a transaction, or claims that directors took action that exceeded their authority
when the action taken is not ultra vires, wasteful, or fraudulent).
88 See 669 A2d at 68.
89 Cf. Sanders v Wang 1999 WL 1044880, at *9 (relevant that board occupied a fiduciary
role as “arbiter of the processes” by which executive compensation plans originated and were
presented to shareholders for approval; court holds shareholders should not be understood to
have read into plan an adjustment mechanism to increase the number of shares that could
be awarded as a consequence of subsequent share splits when prior plans contained such
mechanisms, as did another feature of the contested plan).
90 See Restatement Third, Agency § 4.02(a).
86 See
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not found any significant effect.91 Moreover, the methodology of these event
studies has been challenged because their focus on the moment when directors
adopt a poison pill does not adequately reflect the reality that directors may
adopt a pill at any time, even after a hostile bid emerges.92 Perhaps reflecting
this unsettled state of knowledge, it is rare for corporations’ certificates of incorporation to contain provisions restricting directors’ ability to adopt a poison
pill unilaterally.93
It is also difficult to assess what the practical impact might be were shareholders
to be more generously empowered to adopt by-laws. Topics other than poison
pills — such as executive compensation and the selection and retention of a
corporation’s CEO — might prove attractive subjects for by-law action, necessitating definitional battles over the proper province for a by-law. Nor are a
corporation’s shareholders identical in their preferences. Some may have extramural interests more important than their interests as investors that could
motivate proposals for corporate action via by-law.94 More generally, it is troubling that a generous reading of the by-law power could position shareholders
to exercise power without responsibility for the consequences. Indeed, when the
composition of the shareholding body is in flux, responsibility would be elusive.
Troublesome consequences may also follow for the accountability of directors
within such a regime. It is also noteworthy that commentators who identify
flaws in shareholder voting when its purpose is the election of directors appear
sanguine that comparable flaws would not afflict the process through which a
by-law would be formulated and voted upon by shareholders.95 Finally, it is
open to question whether and how frequently the shareholders of a corporation
that has a poison pill in place are better served by retaining discretion in the
board as opposed to mandating that the pill be redeemed at a particular time.
Mandating redemption could foreclose the possibility of a subsequent deal on
better terms than the bid that prompted the mandate to redeem the pill.96 On
the other hand, directors’ ability to adopt a pill free of the prospect of any
countermand from shareholders may deter initial bids that would otherwise be
made.
91 See

Coates, supra note 37, at 280-86.
at 286-91.
93 Id at 289.
94 Some commentators note that shareholders themselves may present “agency problems”
in relationship to other shareholders. See, eg, Coffee, supra note 51, at 619 (characterising
as “destabilizing” the appearance of labor unions as activist shareholders, and noting that
some unions with token investments have used shareholder activism as a tactic in a collective
bargaining process); Coates, supra note 37, at 334, n 253 (noting relatively poor investment
performance of large public pension fund known to oppose defensive tactics against hostile
take-overs).
95 See Gordon, supra note 17, at 528 (noting that “cognitive assumptions are contradictory”
and commenting that “[i]f shareholders are prone to mistakes in evaluating a hostile bid, why
are they suddenly wiser in deciding how to vote in the related proxy battle presenting the same
issue?”) and 551 (“in giving shareholders the right to choose the residual governance regime,
we should not assume that shareholders will respond in economically irrational ways.”).
96 In Blasius, the court hypothesises a comparable scenario as a circumstance that could
even justify an issuance of shares that would dilute a majority block already acquired by an
initial bidder. See 564 A2d at 662 n 5.
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Conclusion
[5.26] In many respects, the formal structure of corporate law and the mechanisms it creates are incompatible with arguments that rely heavily on an analogy
to simple relationships of common- law agency. Agency explained more about
the relationship between shareholders and directors in an earlier era but that relationship proved incompatible with conducting large-scale enterprises through
the corporate form. The solution, achieved in the United States through statutes
that define the powers of shareholders and directors, in turn makes it plausible to attempt to resolve boundary disputes among powers by reference to the
statute, which leaves little room for arguments grounded in simple agency concepts. Corporate-law systems in the United Kingdom and Australia systematically strengthen the hand dealt to shareholders but do not confer on shareholders the powers of principals in a relationship of common-law agency. The
shareholder-friendlier structure of takeover regulation in the United Kingdom
limits directors’ authority to take defensive measures against unwelcome bids by
requiring a shareholder vote to approve measures that directors propose to take
but does not empower shareholders to give advance instructions to directors.
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